Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.
about
Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.Gene therapy for infectious diseasesA gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitopeNCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maActivation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersCD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive TumorsTargeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibody.Treatment of lymphoma with adoptively transferred T cells.Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation.Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disordersIn vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.AIDS-related malignancies
P2860
Q33762569-82F60B44-30B0-4217-AB6F-FC83C6837968Q33992464-03C6E1F4-442F-4996-9903-70C726534CE6Q35601591-FE5ACC4E-8D54-4782-83CC-25055352EEF8Q35605318-8FB85E61-80B8-4A17-8EA5-977E07BE6AA7Q35621782-A74DC207-F893-4140-9522-DD44C47CC8F1Q35738744-BFBB96BD-186A-4CB5-B35F-D735E4D2C2AAQ36338436-7320C247-5EDF-4E97-84CC-FD7D88F7F0EEQ36367286-8997C6D8-C7E5-4BB1-A523-73E47EAC5D43Q36807231-B7235FC9-3E79-4520-B7A9-E6965F5E8C24Q37220602-5926B199-2433-43E1-94B3-9F85DD2C6E7FQ37419728-7C085E81-744E-496E-96E8-BD70E6D32BB7Q38803361-2459BBDA-2410-41C6-9C5B-4847D0DB40ECQ39707175-0353CDA2-21C7-4FD3-AC56-720025D97F3CQ40725231-CCBAFAE1-7790-4221-A3AF-0BAF0A76AE67Q40924104-4D924545-41AE-454F-A043-69A117958E0CQ42574234-B73801D6-BBCD-47B5-8E81-E4923C1CA437Q43572619-98B6B0C4-851F-486E-B42D-CCC23DD5B43CQ58258998-C8174670-520C-48D3-A682-E440E0EE13F9
P2860
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Administration of neomycin-res ...... unrelated donor marrow grafts.
@en
type
label
Administration of neomycin-res ...... unrelated donor marrow grafts.
@en
prefLabel
Administration of neomycin-res ...... unrelated donor marrow grafts.
@en
P2093
P356
P1433
P1476
Administration of neomycin-res ...... unrelated donor marrow grafts.
@en
P2093
Brenner MK
Roberts WM
Rochester R
P304
P356
10.1089/HUM.1994.5.3-381
P577
1994-03-01T00:00:00Z